Organogenesis Hldgs
(NASDAQ:ORGO)
$2.98
0[0.00%]
At close: Apr 24
$2.98
0[0.00%]
After Hours: 4:01PM EDT
Q1 2024 Earnings in 15 days from now on Thu May 9th, after the market close
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

Organogenesis Hldgs Stock (NASDAQ:ORGO), Quotes and News Summary

Organogenesis Hldgs Stock (NASDAQ: ORGO) stock price, news, charts, stock research, profile.

Open$2.950
Close$2.980
Volume / Avg.2.973M / 754.398K
Day Range2.930 - 3.040
52 Wk Range1.795 - 4.705
Market Cap$393.250M
P/E Ratio74.500
Dividend Yield-
ExchangeNASDAQ
RSI
54
Short Interest
23.73%
Days to Cover13.81

Recent News

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share. Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.
Avi Kapoor
Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Avi Kapoor
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.
Lisa Levin
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
1
Dec 23
1
Feb
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Organogenesis Holdings Inc
Sector
Health Care
Industry
Biotechnology
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufactur...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ORGO
SKYE

FAQ

Q

How do I buy Organogenesis Hldgs (ORGO) stock?

A

You can purchase shares of Organogenesis Hldgs (NASDAQ: ORGO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Organogenesis Hldgs's (ORGO) competitors?

A

Other companies in Organogenesis Hldgs’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Replimune Group (NASDAQ:REPL).

Q

What is the target price for Organogenesis Hldgs (ORGO) stock?

A

The latest price target for Organogenesis Hldgs (NASDAQ: ORGO) was reported by Cantor Fitzgerald on Friday, March 1, 2024. The analyst firm set a price target for 5.00 expecting ORGO to rise to within 12 months (a possible 67.79% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Organogenesis Hldgs (ORGO)?

A

The stock price for Organogenesis Hldgs (NASDAQ: ORGO) is $2.98 last updated April 24, 2024 at 4:01 PM EDT.

Q

Does Organogenesis Hldgs (ORGO) pay a dividend?

A

There are no upcoming dividends for Organogenesis Hldgs.

Q

When is Organogenesis Hldgs (NASDAQ:ORGO) reporting earnings?

A

Organogenesis Hldgs’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Organogenesis Hldgs (ORGO) going to split?

A

There is no upcoming split for Organogenesis Hldgs.

Q

What sector and industry does Organogenesis Hldgs (ORGO) operate in?

A

Organogenesis Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch